Clinical trial
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and…
NCT00293072 · Cambridge University Hospitals NHS Foundation Trust, Other · Completed
Key facts
| NCT number | NCT00293072 |
|---|---|
| Title | Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis |
| Official title | Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis Resistant to Conventional Therapy |
| Lead sponsor | Cambridge University Hospitals NHS Foundation Trust, Other |
| Collaborators | Roche Pharma AG Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Systemic Lupus Erythematosus, ANCA Associated Vasculitis |
| Intervention type | Drug |
| Interventions | Rituximab |
| Enrollment | 20 |
| Start date | Mar 1, 2002 |
| Completion | May 1, 2005 |
| First posted | Feb 17, 2006 |
| Last update posted | Feb 17, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: